Bliss GVS Pharma Limited — Board Meeting, 12-05-2025: Outcome of Board Meeting

Bliss GVS Pharma has announced a board meeting on key financial and strategic actions. The board approved the financial results for the quarter and half-year, with clean audits for both standalone and consolidated accounts. A final dividend of 50% (₹0.50/share) is proposed, subject to shareholder approval. The company will issue up to 12.1 lakh sweat equity shares to Managing Director Gagan Harsh Sharma and Vice President Vishal Vijay Rao in recognition of their contributions. Its wholly owned subsidiary sold a 51% stake in Nigerian Greenlife Bliss Healthcare for USD 1.3 million. Auditors have been appointed for the next five years.